Trials

Cosmo Pharmaceuticals Announces Release of Aemcolo ™ Report on Itching Diarrhea in Clinical Trials | 06/21/19

Dublin – June 21, 2019 – Cosmo Pharmaceuticals NV (SIX: COPN), a leading specialty pharmaceutical company in the field of certain gastrointestinal diseases and endoscopy, announced today the publication of a review of Aemcolo ™, the broad-spectrum oral antibiotic, as part of a clinical trial focusing on its safety, efficacy and benefits compared to other …

Cosmo Pharmaceuticals Announces Release of Aemcolo ™ Report on Itching Diarrhea in Clinical Trials | 06/21/19 Read More »